Standard Test Method for Analysis of Hemolytic Properties of Nanoparticles


Importancia y uso:

5.1 This test method is one of a series of tests listed in Practice F748 and ISO 10993-4 to assess the biocompatibility of materials contacting blood in medical applications.

5.2 This test method is similar to Practice F756 but modified to accommodate nanoparticulate materials.

Subcomité:

E56.03

Referida por:

F0756-17

Volúmen:

14.02

Número ICS:

11.100.01 (Laboratory medicine in general)

Palabras clave:

hemolysis; nanoparticulate; plasma; whole blood;

$ 1,086

Agregar al carrito

Norma
E2524

Versión
22

Estatus
Active

Clasificación
Test Method

Fecha aprobación
2022-09-01